Clinical Trials
11 trialsNCT07612007 2026-06-01
HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
Mayo Clinic
Phase 2 Not yet recruiting
NCT04597710 2026-05-29
Precision1
Perspectum
Completed
NCT07581769 2026-05-14
Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging
First Affiliated Hospital, Sun Yat-Sen University
Active not recruiting
NCT07587216 2026-05-14
Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
Tongji Hospital
Recruiting
NCT05349331 2026-01-15
WATCH
Sun Yat-sen University
Phase 2 Completed
NCT03844750 2025-12-31
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases
University of California, San Francisco
Phase 2 Terminated
NCT03432806 2025-12-02
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT07142876 2025-08-27
Evaluation Of Liver Resection Using Harmonic Scalpel Versus Cavitron Ultrasonic Surgical Aspirator (CUSA).
Sohag University
Phase NA Not yet recruiting
NCT02892305 2025-08-06
Hepatic Resection for Metastatic Pancreatic Cancer
Duke University
Active not recruiting
NCT06248528 2025-07-16
Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.
Tongji Hospital
Phase NA Active not recruiting
NCT07030842 2025-06-29
Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma
Tongji Hospital
Completed